| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $15.69 ▼ -0.80% | Yesterday | $15.87 ▲ +0.33% | Tomorrow's Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) setup is anchored to $15.82 and targets $15.69 (-0.80%). The near-term read is downside; watch $16.29 / $15.35 because daily realized volatility is about 4.10%. |
Tomorrow's Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) setup is anchored to $15.82 and targets $15.69 (-0.80%). The near-term read is downside; watch $16.29 / $15.35 because daily realized volatility is about 4.10%. | ||||
| Week | $15.43 ▼ -2.48% | Last Week | $15.98 ▲ +1.04% | The 7-day Aurinia Pharmaceuticals Inc Ordinary Shares model moves from $15.98 to $15.43 (-2.48%). It gives downside momentum context for this stock, so breaks around $16.29 / $15.35 matter more than a single tick. |
The 7-day Aurinia Pharmaceuticals Inc Ordinary Shares model moves from $15.98 to $15.43 (-2.48%). It gives downside momentum context for this stock, so breaks around $16.29 / $15.35 matter more than a single tick. | ||||
| Month | $14.99 ▼ -5.27% | Last Month | $16.17 ▲ +2.21% | The 1-month Aurinia Pharmaceuticals Inc Ordinary Shares target is $14.99 (-5.27%), compared with the live reference near $15.82. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Aurinia Pharmaceuticals Inc Ordinary Shares target is $14.99 (-5.27%), compared with the live reference near $15.82. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $14.32 ▼ -9.46% | Last Year | $16.45 ▲ +3.97% | The 1-year Aurinia Pharmaceuticals Inc Ordinary Shares scenario points to $14.32 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Aurinia Pharmaceuticals Inc Ordinary Shares scenario points to $14.32 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $12.77 ▼ -19.29% | 5 Years Ago | $17.10 ▲ +8.10% | The 5-year Aurinia Pharmaceuticals Inc Ordinary Shares view is $12.77 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Aurinia Pharmaceuticals Inc Ordinary Shares view is $12.77 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $15.82 | Mid |
| Daily Change | -0.88% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 59% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $15.82 | Daily Change | -0.88% |
| Market Cap | $2.10B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.